EP1023083A4 - Veterinary vaccines - Google Patents

Veterinary vaccines

Info

Publication number
EP1023083A4
EP1023083A4 EP98949828A EP98949828A EP1023083A4 EP 1023083 A4 EP1023083 A4 EP 1023083A4 EP 98949828 A EP98949828 A EP 98949828A EP 98949828 A EP98949828 A EP 98949828A EP 1023083 A4 EP1023083 A4 EP 1023083A4
Authority
EP
European Patent Office
Prior art keywords
veterinary vaccines
vaccines
veterinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98949828A
Other languages
German (de)
French (fr)
Other versions
EP1023083A1 (en
Inventor
Richard Buchta
Christopher Leigh Schwartzkoff
Philip Ralph Lehrbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9722035.4A external-priority patent/GB9722035D0/en
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of EP1023083A1 publication Critical patent/EP1023083A1/en
Publication of EP1023083A4 publication Critical patent/EP1023083A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
EP98949828A 1997-10-17 1998-10-16 Veterinary vaccines Withdrawn EP1023083A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9722035 1997-10-17
GBGB9722035.4A GB9722035D0 (en) 1997-10-17 1997-10-17 Veterinary vaccines
PCT/AU1998/000865 WO1999020305A1 (en) 1997-10-17 1998-10-16 Veterinary vaccines

Publications (2)

Publication Number Publication Date
EP1023083A1 EP1023083A1 (en) 2000-08-02
EP1023083A4 true EP1023083A4 (en) 2006-06-14

Family

ID=25641911

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98949828A Withdrawn EP1023083A4 (en) 1997-10-17 1998-10-16 Veterinary vaccines

Country Status (5)

Country Link
EP (1) EP1023083A4 (en)
AU (1) AU753804B2 (en)
CA (1) CA2307000C (en)
NZ (1) NZ503636A (en)
WO (1) WO1999020305A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824279B1 (en) * 2001-05-04 2004-05-28 Seppic Sa CONCENTRATED W / O EMULSION
FR2824269B1 (en) * 2001-09-03 2012-03-02 Seppic Sa ADJUVANT COMPOSITION CONSISTING OF 1% TO 15% OF SURFACTANTS AT GLOBAL HLB INCLUDING BETWEEN 5 AND 8 AND 85% TO 99% OF BODY FATS
GB2448440B (en) * 2005-12-15 2011-05-04 Hancroft Pty Ltd A method for preventing reduced feed intake in animals and treatment of disease conditions
FR2903602B1 (en) * 2006-07-12 2012-10-26 Seppic Sa INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME
FR2922767B1 (en) 2007-10-24 2009-12-18 Seppic Sa PROCESS FOR PREPARING A VACCINE COMPOSITION COMPRISING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT
CN106177935A (en) * 2016-08-19 2016-12-07 齐鲁动物保健品有限公司 A kind of ruminant clostridial disease tetrad inactivated vaccine and preparation method thereof
GB201718251D0 (en) * 2017-11-03 2017-12-20 Univ Sydney Vaccine Compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
US5424067A (en) * 1989-07-03 1995-06-13 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Injectable multi-phase emulsions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843451A (en) * 1970-08-20 1974-10-22 Burroughs Wellcome Co Microorganism production
FR2717694B1 (en) * 1994-03-22 1996-05-03 Seppic Sa A composition comprising a recombinant plasmid and its uses as a vaccine and medicament.
US5814321A (en) * 1995-11-30 1998-09-29 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Oil adjuvant vaccine and method for preparing same
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
US5424067A (en) * 1989-07-03 1995-06-13 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Injectable multi-phase emulsions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
D.E.S. STEWART-HULL ET AL.: "Immunosuppressive effect in mycobacterial adjuvant emulsions of mineral oils containing low molecular weight hydrocarbons", INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, vol. 52, no. 1-4, 1976, CHBASEL, pages 118 - 128, XP008063925 *
See also references of WO9920305A1 *

Also Published As

Publication number Publication date
NZ503636A (en) 2002-05-31
WO1999020305A8 (en) 1999-07-08
AU753804B2 (en) 2002-10-31
WO1999020305A1 (en) 1999-04-29
CA2307000C (en) 2011-01-04
AU9616198A (en) 1999-05-10
CA2307000A1 (en) 1999-04-29
EP1023083A1 (en) 2000-08-02

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9727262D0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
IL128985A0 (en) Vaccines
EP0958373A4 (en) Vaccines
GB9410922D0 (en) Vaccines
GB9822714D0 (en) Vaccines
GB9626864D0 (en) Vaccine
EP1023083A4 (en) Veterinary vaccines
ZA982763B (en) Vaccines
GB9625968D0 (en) Vaccine
ZA9711530B (en) Veterinary vaccines
GB9722035D0 (en) Veterinary vaccines
GB9609252D0 (en) Vaccines
GB9702920D0 (en) Vaccines
ZA952806B (en) Vaccines
GB9608106D0 (en) Animal Vaccines
GB9720982D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9717423D0 (en) Vaccine
GB9606032D0 (en) Vaccines
GB9604596D0 (en) Vaccines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20000404;LT PAYMENT 20000404;LV PAYMENT 20000404;MK PAYMENT 20000404;RO PAYMENT 20000404;SI PAYMENT 20000404

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: WYETH

A4 Supplementary search report drawn up and despatched

Effective date: 20060517

17Q First examination report despatched

Effective date: 20061215

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090505